MedPath
HSA Approval

NIZOLE TABLET 200 mg

SIN08077P

NIZOLE TABLET 200 mg

NIZOLE TABLET 200 mg

March 18, 1995

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01XD01

metronidazole

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

HOVID Bhd.

Active Ingredients

METRONIDAZOLE

200MG

Metronidazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NIZOLE TABLET 200 mg - HSA Approval | MedPath